Meeting Report

Staying Abreast of New Biomarkers in Hematology/Oncology

Presented by Andrew Guinigundo,(1) MSN, RN, CNP, ANP-BC, FAPO, and Grace Baek,(2) PharmD, BCOP

From (1)Cincinnati Cancer Advisors, Cincinnati, Ohio; (2)Fred Hutchinson Cancer Center/ UW Medicine, Seattle, Washington

Presenters’ disclosures of conflicts of interest are found at the end of this article.

ABSTRACT

There has been an increasing number of approvals for targeted therapies in oncology in the past decade, changing the treatment paradigm for many solid tumors and hematologic malignancies. At JADPRO Live 2023, presenters provided an in-depth review of cancer biomarkers, including testing methodology, recommended therapies, and how advanced practitioners can integrate results into clinical decision-making.

For access to the full length article, please sign in.